{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:11:05Z","timestamp":1792228265037,"version":"4.4.0"},"reference-count":59,"publisher":"SAGE Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2019,12,12]]},"DOI":"10.3233\/jad-190615","type":"journal-article","created":{"date-parts":[[2019,11,13]],"date-time":"2019-11-13T08:19:40Z","timestamp":1573633180000},"page":"1353-1361","source":"Crossref","is-referenced-by-count":89,"title":["Neurofilament Light Chain in Cerebrospinal Fluid and Blood as a Biomarker for Neurodegenerative Diseases: A Systematic Review and Meta-Analysis"],"prefix":"10.1177","volume":"72","author":[{"given":"Shao-Yang","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie-Qiong","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-He","family":"Hou","sequence":"additional","affiliation":[{"name":"Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Nan","family":"Ou","sequence":"additional","affiliation":[{"name":"Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Tai","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Neurology and Institute of Neurology, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Tan","sequence":"additional","affiliation":[{"name":"Department of Neurology, Qingdao Municipal Hospital, Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-190615_ref1","unstructured":"(2017) What is neurodegenerative disease? JPND Research, https:\/\/www.neurodegenerationresearch.eu\/about\/what\/."},{"key":"10.3233\/JAD-190615_ref2","doi-asserted-by":"crossref","first-page":"a018309","DOI":"10.1101\/cshperspect.a018309","article-title":"Neurofilaments and neurofilament proteins in health and disease","volume":"9","author":"Yuan","year":"2017","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.3233\/JAD-190615_ref3","doi-asserted-by":"crossref","first-page":"e75091","DOI":"10.1371\/journal.pone.0075091","article-title":"Increased neurofilament light chain blood levels in neurodegenerative neurological diseases","volume":"8","author":"Gaiottino","year":"2013","journal-title":"PLoS One"},{"key":"10.3233\/JAD-190615_ref4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1083\/jcb.74.1.241","article-title":"Immunofluorescence studies of neurofilaments in the rat and human peripheral and central nervous system","volume":"74","author":"Schlaepfer","year":"1977","journal-title":"J Cell Biol"},{"key":"10.3233\/JAD-190615_ref5","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/s41582-018-0058-z","article-title":"Neurofilaments as biomarkers in neurological disorders","volume":"14","author":"Khalil","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-190615_ref6","doi-asserted-by":"crossref","first-page":"e0164625","DOI":"10.1371\/journal.pone.0164625","article-title":"Neurofilaments as biomarkers for amyotrophic lateral sclerosis: a systematic review and meta-analysis","volume":"11","author":"Xu","year":"2016","journal-title":"PLoS One"},{"key":"10.3233\/JAD-190615_ref7","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1212\/WNL.0000000000001015","article-title":"CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival","volume":"83","author":"Skillback","year":"2014","journal-title":"Neurology"},{"key":"10.3233\/JAD-190615_ref8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.parkreldis.2008.05.001","article-title":"Levels of brain related proteins in cerebrospinal fluid: an aid in the differential diagnosis of parkinsonian disorders","volume":"15","author":"Constantinescu","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JAD-190615_ref9","first-page":"187","article-title":"Cerebrospinal fluid biomarker candidates for parkinsonian disorders","volume":"3","author":"Constantinescu","year":"2012","journal-title":"Front Neurol"},{"key":"10.3233\/JAD-190615_ref10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuron.2016.06.030","article-title":"Neurofilament light: a dynamic cross-disease fluid biomarker for neurodegeneration","volume":"91","author":"Zetterberg","year":"2016","journal-title":"Neuron"},{"key":"10.3233\/JAD-190615_ref11","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.3233\/JAD-190615_ref12","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta8250","article-title":"Development and validation of methods for assessing the quality of diagnostic accuracy studies","volume":"8","author":"Whiting","year":"2004","journal-title":"Health Technol Assess"},{"key":"10.3233\/JAD-190615_ref13","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/0003-4819-138-1-200301070-00012-w1","article-title":"The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration","volume":"138","author":"Bossuyt","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.3233\/JAD-190615_ref14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2288-7-10","article-title":"Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews","volume":"7","author":"Shea","year":"2007","journal-title":"BMC Med Res Methodol"},{"key":"10.3233\/JAD-190615_ref15","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","article-title":"CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"15","author":"Olsson","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-190615_ref16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-2288-8-32","article-title":"The ratio of means method as an alternative to mean differences for analyzing continuous outcome variables in meta-analysis: a simulation study","volume":"8","author":"Friedrich","year":"2008","journal-title":"BMC Med Res Methodol"},{"key":"10.3233\/JAD-190615_ref17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.3233\/JAD-190615_ref18","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jamaneurol.2015.3037","article-title":"Association of cerebrospinal fluid neurofilament light concentration with Alzheimer disease progression","volume":"73","author":"Zetterberg","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-190615_ref19","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3233\/JAD-2010-090649","article-title":"CSF neurofilament proteins levels are elevated in sporadic Creutzfeldt-Jakob disease","volume":"21","author":"van Eijk","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-190615_ref20","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1212\/WNL.54.10.1960","article-title":"Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD","volume":"54","author":"Sjogren","year":"2000","journal-title":"Neurology"},{"key":"10.3233\/JAD-190615_ref21","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/ana.24052","article-title":"Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration","volume":"75","author":"Scherling","year":"2014","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-190615_ref22","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000099473","article-title":"CSF neurofilaments in frontotemporal dementia compared with early onset Alzheimer\u2019s disease and controls","volume":"23","author":"Pijnenburg","year":"2007","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-190615_ref23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13195-018-0361-3","article-title":"Cerebrospinal fluid in the differential diagnosis of Alzheimer\u2019s disease: clinical utility of an extended panel of biomarkers in a specialist cognitive clinic","volume":"10","author":"Paterson","year":"2018","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-190615_ref24","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1136\/jnnp-2014-309562","article-title":"A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromes","volume":"86","author":"Magdalinou","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-190615_ref25","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.neuint.2017.05.010","article-title":"Diagnostic accuracy of CSF neurofilament light chain protein in the biomarker-guided classification system for Alzheimer\u2019s disease","volume":"108","author":"Lista","year":"2017","journal-title":"Neurochem Int"},{"key":"10.3233\/JAD-190615_ref26","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2377-13-54","article-title":"Cerebrospinal fluid neurofilament light chain protein levels in subtypes of frontotemporal dementia","volume":"13","author":"Landqvist Waldo","year":"2013","journal-title":"BMC Neurol"},{"key":"10.3233\/JAD-190615_ref27","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1001\/archneurol.2012.1654","article-title":"Accuracy of a panel of 5 cerebrospinal fluid biomarkers in the differential diagnosis of patients with dementia and\/or parkinsonian disorders","volume":"69","author":"Hall","year":"2012","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-190615_ref28","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1212\/WNL.0000000000004088","article-title":"CSF sAPPbeta, YKL-40, and neurofilament light in frontotemporal lobar degeneration","volume":"89","author":"Alcolea","year":"2017","journal-title":"Neurology"},{"key":"10.3233\/JAD-190615_ref29","doi-asserted-by":"crossref","first-page":"551","DOI":"10.3233\/JAD-180409","article-title":"Cerebrospinal fluid biomarkers in patients with frontotemporal dementia spectrum: a single-center study","volume":"66","author":"Abu-Rumeileh","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-190615_ref30","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/21678421.2017.1281962","article-title":"Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survival","volume":"18","author":"Skillback","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.3233\/JAD-190615_ref31","doi-asserted-by":"crossref","first-page":"e1231","DOI":"10.1212\/WNL.0000000000005261","article-title":"Clinical value of neurofilament and phospho-tau\/tau ratio in the frontotemporal dementia spectrum","volume":"90","author":"Meeter","year":"2018","journal-title":"Neurology"},{"key":"10.3233\/JAD-190615_ref32","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1001\/jamaneurol.2016.5398","article-title":"Diagnostic and prognostic biomarkers in amyotrophic lateral sclerosis: neurofilament light chain levels in definite subtypes of disease","volume":"74","author":"Gaiani","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-190615_ref33","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13195-017-0331-1","article-title":"The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias","volume":"10","author":"Abu-Rumeileh","year":"2018","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-190615_ref34","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fneur.2015.00091","article-title":"CSF neurofilament light chain but not FLT3 ligand discriminates parkinsonian disorders","volume":"6","author":"Herbert","year":"2015","journal-title":"Front Neurol"},{"key":"10.3233\/JAD-190615_ref35","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1212\/WNL.0000000000003680","article-title":"Blood-based NfL: A biomarker for differential diagnosis of parkinsonian disorder","volume":"88","author":"Hansson","year":"2017","journal-title":"Neurology"},{"key":"10.3233\/JAD-190615_ref36","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/mds.26578","article-title":"Longitudinal measurements of cerebrospinal fluid biomarkers in Parkinson\u2019s disease","volume":"31","author":"Hall","year":"2016","journal-title":"Mov Disord"},{"key":"10.3233\/JAD-190615_ref37","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jamaneurol.2015.1449","article-title":"Cerebrospinal fluid patterns and the risk of future dementia in early, incident Parkinson disease","volume":"72","author":"Backstrom","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-190615_ref38","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.parkreldis.2018.06.018","article-title":"Serum neurofilament light chain in progressive supranuclear palsy","volume":"56","author":"Donker Kaat","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JAD-190615_ref39","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1080\/21678421.2016.1241279","article-title":"Diagnostic and prognostic significance of neurofilament light chain NF-L, but not progranulin and S100B, in the course of amyotrophic lateral sclerosis: Data from the German MND-net","volume":"18","author":"Steinacker","year":"2017","journal-title":"Amyotroph Lateral Scler Frontotemporal Degener"},{"key":"10.3233\/JAD-190615_ref40","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/ana.24552","article-title":"Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis","volume":"79","author":"Weydt","year":"2016","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-190615_ref41","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1002\/acn3.212","article-title":"CSF neurofilament light chain reflects corticospinal tract degeneration in ALS","volume":"2","author":"Menke","year":"2015","journal-title":"Ann Clin Transl Neurol"},{"key":"10.3233\/JAD-190615_ref42","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1212\/01.WNL.0000098880.19793.B6","article-title":"Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS","volume":"61","author":"Malmestrom","year":"2003","journal-title":"Neurology"},{"key":"10.3233\/JAD-190615_ref43","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/ana.22247","article-title":"Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab","volume":"69","author":"Gunnarsson","year":"2011","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-190615_ref44","doi-asserted-by":"crossref","first-page":"38737","DOI":"10.1038\/srep38737","article-title":"Neurofilaments in blood and CSF for diagnosis and prediction of onset in Creutzfeldt-Jakob disease","volume":"6","author":"Steinacker","year":"2016","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-190615_ref45","doi-asserted-by":"crossref","first-page":"e0163479","DOI":"10.1371\/journal.pone.0163479","article-title":"Cerebrospinal fluid inflammatory biomarkers reflect clinical severity in Huntington\u2019s disease","volume":"11","author":"Rodrigues","year":"2016","journal-title":"PLoS One"},{"key":"10.3233\/JAD-190615_ref46","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.parkreldis.2008.05.012","article-title":"Levels of the light subunit of neurofilament triplet protein in cerebrospinal fluid in Huntington\u2019s disease","volume":"15","author":"Constantinescu","year":"2009","journal-title":"Parkinsonism Relat Disord"},{"key":"10.3233\/JAD-190615_ref47","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1001\/jamaneurol.2016.6117","article-title":"Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease","volume":"74","author":"Mattsson","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-190615_ref48","doi-asserted-by":"crossref","first-page":"17368","DOI":"10.1038\/s41598-018-35766-w","article-title":"Levels of plasma neurofilament light chain and cognitive function in patients with Alzheimer or Parkinson disease","volume":"8","author":"Lin","year":"2018","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-190615_ref49","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13195-018-0404-9","article-title":"Plasma neurofilament light as a potential biomarker of neurodegeneration in Alzheimer\u2019s disease","volume":"10","author":"Lewczuk","year":"2018","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-190615_ref50","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s40478-018-0649-3","article-title":"Increased plasma neurofilament light chain concentration correlates with severity of post-mortem neurofibrillary tangle pathology and neurodegeneration","volume":"7","author":"Ashton","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JAD-190615_ref51","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1212\/WNL.0000000000003154","article-title":"Serum neurofilament light chain protein is a measure of disease intensity in frontotemporal dementia","volume":"87","author":"Rohrer","year":"2016","journal-title":"Neurology"},{"key":"10.3233\/JAD-190615_ref52","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1007\/s00415-018-8893-9","article-title":"Serum neurofilament light is increased in multiple system atrophy of cerebellar type and in repeat-expansion spinocerebellar ataxias: a pilot study","volume":"265","author":"Wilke","year":"2018","journal-title":"J Neurol"},{"key":"10.3233\/JAD-190615_ref53","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1212\/WNL.52.5.1090","article-title":"Neurofilament protein levels in CSF are increased in dementia","volume":"52","author":"Rosengren","year":"1999","journal-title":"Neurology"},{"key":"10.3233\/JAD-190615_ref54","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1023832305702","article-title":"Alzheimer\u2019s disease as a disconnection syndrome?","volume":"13","author":"Delbeuck","year":"2003","journal-title":"Neuropsychol Rev"},{"key":"10.3233\/JAD-190615_ref55","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/ana.410100209","article-title":"Some morphometric aspects of the brain in senile dementia of the Alzheimer type","volume":"10","author":"Terry","year":"1981","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-190615_ref56","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3233\/JAD-2006-9S308","article-title":"Clinicopathological analysis of dementia disorders in the elderly\u2013an update","volume":"9","author":"Jellinger","year":"2006","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-190615_ref57","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0167-4943(87)90021-5","article-title":"Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology","volume":"6","author":"Brun","year":"1987","journal-title":"Arch Gerontol Geriatr"},{"key":"10.3233\/JAD-190615_ref58","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/ana.410440116","article-title":"Frontotemporal dementia: neuropil spheroids and presynaptic terminal degeneration","volume":"44","author":"Zhou","year":"1998","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-190615_ref59","first-page":"1","article-title":"Amyotrophic lateral sclerosis \u2013 looking for pathogenesis and effective therapy","volume":"49","author":"Naganska","year":"2011","journal-title":"Folia Neuropathol"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-190615","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:07:06Z","timestamp":1777370826000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-190615"}},"subtitle":[],"editor":[{"given":"Ling-Qiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,12,12]]},"references-count":59,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jad-190615","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,12]]}}}